ECancer

What ECancer does

ECancer is an oncology-focused medical-education organization that produces and distributes free, peer-reviewed clinical content and digital learning resources to cancer healthcare professionals worldwide. Its primary asset is the open-access journal ecancermedicalscience, complemented by CME-accredited e-learning courses, conference coverage, and multimedia content, with a stated emphasis on serving clinicians in low- and middle-income countries who face paywalled access to mainstream oncology literature.

The organization operates ecancer.org as its main distribution channel and is structured around a UK charitable entity with an affiliated foundation (ecancer Global Foundation) that channels grants and donations. Content production relies on a network of contributing oncologists, peer reviewers, and editorial staff; sponsorship and grant funding from pharmaceutical companies, oncology societies, and academic institutions underwrite the free-access model rather than subscription fees.

Commercially, ECancer's revenue mechanics are characteristic of a non-profit med-ed publisher: income is grant- and sponsorship-driven, episodic, and dependent on a small set of repeat funders, while the user/reader side is free and unmonetized. This structure produces thin operating margins, limited pricing power, and sensitivity to shifts in pharma medical-education budgets, and constrains the organization's ability to invest heavily in differentiated technology, proprietary data assets, or AI-native capabilities.

Name

ECancer

Legal name

eCancer Global Foundation

Website

https://ecancer.org

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

ECancer is a UK-based oncology-education organization that publishes the open-access journal ecancermedicalscience and offers CME-accredited e-learning resources to cancer clinicians worldwide, with emphasis on low- and middle-income countries, funded primarily via grants and sponsorships.

Ownership category

akta.pro rank

Product category

Oncology Medical Education

NAICS

Educational Support Services (61171)

SIC

Services-Educational Services (8200)

akta.pro primary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

Keywords

• Oncology education
• Medical e-learning
• Open access publishing
• Cancer research
• CME-accredited training

Headquarters

HQ city

Bristol

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Grants and Educational Funding: ecancer receives funding from pharmaceutical companies as educational grants and sponsorships for CME-accredited content and educational programs.
2. Charitable Donations: Individual donations and charitable contributions from individuals supporting cancer education worldwide.
3. EU and Statutory Funding: European Union research project funding and statutory funding programs supporting dissemination of cancer research findings.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

ECancer provides a free, open-access digital oncology education platform that publishes daily cancer news, a peer-reviewed open-access journal (CC BY 3.0 licensed), expert video interviews, CME-accredited e-learning modules, and on-site video coverage of major oncology conferences (ASCO, EHA, ESMO). All content is provided at no cost, with English and Spanish language support, targeting oncology healthcare professionals and, via a separate eCancer Patient portal, cancer patients and caregivers.

Product overview

ECancer is an open access oncology education platform offering multiple integrated services: a peer-reviewed journal, daily cancer news, educational videos with expert interviews, CME-accredited eLearning modules, and conference coverage. The platform is accessible in English and Spanish and focuses on supporting oncology professionals worldwide through evidence-based medical education. The organization also maintains a separate patient-facing resource at ecancerpatient.org. All journal articles are published under CC BY 3.0 licence, while videos and educational content use CC BY-NC-ND 3.0 licence.

Differentiator

Problem solved

Functional benefit

Products and services

• News Daily oncology news service publishing articles on cancer research developments, clinical trials, and oncology advancements from global sources, targeted at healthcare professionals.
• Journal (ecancer) Open-access peer-reviewed oncology journal publishing research articles across all cancer types, covered by the Attribution 3.0 Unported (CC BY 3.0) Creative Commons licence and indexed with Crossref DOIs.
• Videos Medical education video library of expert interviews and conference presentations featuring oncologists discussing research findings and clinical practice updates, hosted on the ecancer platform with Vimeo integration.
• eLearning CME-accredited online educational modules for healthcare professionals covering cancer diagnosis, treatment, and management across multiple oncology specialties.
• Conferences On-site conference coverage service providing video reports, news summaries, and expert interviews from major oncology meetings including ASCO, EHA, and ESMO.
• eCancer Patient Separate patient-focused resource platform providing cancer information and education materials for cancer patients and their caregivers.

Quantifiable outcome

• Supporting tens of thousands of medical professionals monthly worldwide

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• RH4C-MENAcoreStrategic or Co-development PartnerResearch for Health in Conflict: developing capability, partnerships and research in the Middle East and North Africa. ecancer serves as communication and dissemination partner for this European-funded research project.
• PIONEERcoreStrategic or Co-development PartnerThe European network of excellence for big data in prostate cancer. ecancer supports communication and dissemination of project findings to the healthcare community.
• iManageCancerminorStrategic or Co-development PartnerEmpowering patients and strengthening self-management in cancer diseases. Completed EU research project where ecancer created tailored educational resources and project website.
• P-MedicineminorStrategic or Co-development PartnerPersonalised medicine research project. Completed EU-funded project focused on advancing personalized medicine research.
• EurocanplatformminorStrategic or Co-development PartnerEuropean Commission funded project bringing together 28 European cancer institutions and organisations. ecancer contributed to collaboration advancing cancer research and treatment.
• E-PossomminorStrategic or Co-development PartnerOnline learning project for surgeons. Completed educational project focused on surgical oncology training.
• EurecaminorStrategic or Co-development PartnerEnabling information re-use by linking clinical research and care. Completed EU project focused on health data interoperability.
• Open Access Scholarly Publishers Association (OASPA)minorOthersecancer is a member of OASPA, promoting open access publishing standards and integrity in academic communication.
• Committee on Publication Ethics (COPE)minorOthersMember organization promoting integrity in research publication. ecancer follows COPE guidelines for ethical publishing practices.
• Healthcare Information For All (HIFA)minorOthersGlobal campaign for healthcare information for all. ecancer supports the mission of improving access to healthcare knowledge in developing countries.

Scale indicators2 records

Recent moves4 records

Expansion highlights3 records

Emerging players

• Healio (SLACK Incorporated): Healio provides specialty-focused medical news, journal content, and CME across multiple specialties including oncology — competing for clinician mindshare and pharma educational sponsorship alongside ecancer.

Direct peers

• Medscape (WebMD Health): Medscape is the largest free, CME-accredited medical education platform globally. Like ecancer, it monetizes via pharma educational grants and serves clinicians with news, journal content, and CME — but across all specialties rather than oncology alone.
• Cancer Therapy Advisor (Haymarket Media): Cancer Therapy Advisor is an oncology-focused clinical news and education resource serving oncologists with news, conference coverage, and CME — directly comparable to ecancer's news and video offerings.
• VJOncology: VJOncology is a video-led oncology education platform featuring expert interviews, conference coverage, and CME content for practicing oncologists — a near-direct competitor in the video / KOL-interview niche.
• OncLive (MJH Life Sciences): OncLive is a leading oncology-focused digital media and education platform offering news, video interviews, conference coverage, and CME for practicing oncologists — directly overlapping ecancer's product mix and pharma-funded business model.

Broad incumbents

• BMJ Learning: BMJ Learning is a large, accredited CME provider serving a global clinician base. While it spans all specialties, its oncology modules and reach into Europe overlap with ecancer's CME and open-access ethos.
• ASCO (American Society of Clinical Oncology): ASCO is the largest professional oncology society and runs its own education platforms, journals (JCO), meeting coverage, and CME programs. It competes with ecancer for both clinician attention and pharma educational-grant sponsorship.
• ESMO (European Society for Medical Oncology): ESMO is the leading European oncology society producing its own congress content, journals (Annals of Oncology), and CME programs — overlapping with ecancer's European reach and conference-coffering activities.
• Doctor's Digest / Pri-Med: Pri-Med is a large free CME and clinician-education platform funded by pharma grants. It competes more broadly across primary-care specialties but its pharma-funded CME model mirrors ecancer's monetization approach.

Others

• Nature Reviews Cancer: Nature Reviews Cancer is a top-tier oncology review journal with high KOL readership and pharma reach. It is adjacent rather than directly competing, but competes for high-quality oncology content authors and CME-eligible content.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/ecancer
• Facebookfacebook.com/ecancer

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ECancer